Meditrina Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.15 M
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 11.04%
- Profit Growth -38.36%
- Ebitda 94.58%
- Net Worth 14.10%
- Total Assets 2.63%
About Meditrina Life Sciences
Meditrina Life Sciences Private Limited (MLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 September 2012 and has a history of 12 years and four months. Its registered office is in Nashik, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Avinash Nikam and Maheshkumar Chandrakant serve as directors at the Company.
Company Details
-
Location
Nashik, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2012PTC235503
-
Company No.
235503
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Sep 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Meditrina Life Sciences Private Limited offer?
Meditrina Life Sciences Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Cardiovascular Drugs & Medication, Diabetes Medicine.
Who are the key members and board of directors at Meditrina Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avinash Nikam
|
Director | 10-Sep-2012 | Current |
|
Maheshkumar Chandrakant
|
Director | 10-Sep-2012 | Current |
Financial Performance of Meditrina Life Sciences.
Meditrina Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.04% increase. The company also saw a substantial fall in profitability, with a 38.36% decrease in profit. The company's net worth Soared by an impressive increase of 14.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meditrina Life Sciences?
In 2021, Meditrina Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Trade Stone Securities LlpAvinash Nikam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Meditrina Life Sciences?
Unlock and access historical data on people associated with Meditrina Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meditrina Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meditrina Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
